Latest Announcements

Speciality Restaurants Limited held its 27th Annual General Meeting on September 11, 2026, through video conferencing. The meeting was attended by all directors and key managerial personnel, and the requisite quorum was present. The company secretary informed members about the e-voting facility and the appointment of a scrutinizer to oversee the process. The chairman responded to queries and clarified matters raised by members.

Dr. Reddy's Laboratories Limited has informed the Exchange about a USFDA records assessment at its API manufacturing facility in Mexico, with two observations issued and a response timeline stipulated.

Toyam Sports Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 18/09/2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter ended June 30, 2026.

Dr Reddys Laboratories Ltd has informed that the USFDA has completed a records assessment at its API manufacturing facility in Mexico, with two observations noted, and the company will respond within the stipulated timeline.

Prism Johnson Ltd has announced a schedule for an analyst/investor conference to be held on September 17, 2026, in Mumbai, where the company will discuss historical data and publicly available information.

Lloyds Engineering Works Ltd has announced a meeting of equity shareholders to consider a scheme of merger by absorption of three companies, Lloyds Infrastructure & Construction Ltd, Metalfab Hightech Private Ltd, and Techno Industries Private Ltd, with the company.

Multi Commodity Exchange of India Ltd has announced the schedule of an Analyst / Investor meeting to be held on September 18, 2026, with RatnaTraya Capital. The meeting will be held virtually and the information will also be available on the company's website.

Prism Johnson Limited has informed the Exchange about the schedule of an analyst/investor conference to be held on September 17, 2026, in Mumbai, where discussions will center around historical data and publicly available information.

Raymond Lifestyle Limited has informed the Exchange about a schedule of meet for investor conferences on September 17, 2026, at The Oberoi, Gurgaon.

Credo Brands Marketing Limited has informed BSE about the re-appointment of an Executive Director.

Strides Pharma Science Limited has informed the Exchange about the completion of a USFDA inspection at its Formulations Facility at Alathur, which resulted in a Form 483 with three observations. The company will respond to these observations within the stipulated time.

Raymond Lifestyle Ltd has informed about its participation in investor conferences on September 17, 2026, at The Oberoi, Gurgaon, hosted by Jefferies - 5th India Meet Forum.

Credo Brands Marketing Limited has informed the Exchange regarding the appointment of Mr. Kamal Khushlani as Chairman & Managing Director of the company, effective March 08, 2027.

Rolex Rings Ltd has informed BSE and NSE about attending an investors conference in Singapore on September 18, 2026, as per SEBI regulations.

Quint Digital Ltd has announced the allotment of 82,61,401 Partly Paid-Up 10% Non-Cumulative Non-Participating Compulsorily Convertible Preference Shares (CCPS) and 82,61,401 Partly Paid-Up Detachable Warrants at an issue price of ₹ 100 per CCPS and ₹ 10 per Warrant respectively, as part of its Rights Issue.

Credo Brands Marketing Ltd has announced the reappointment of Mr. Kamal Khushlani as Chairman and Managing Director for five years, effective from March 08, 2027.

Jaihind Industries Ltd has informed the Exchange regarding the Outcome of Board Meeting held on September 11, 2026.

Oswal Overseas Ltd has submitted a letter explaining the reasons for the delay in submitting its financial results for the period/year ended June 30, 2026.

Diligent Media Corporation Ltd has submitted its Annual Report for FY 2025-26, along with a notice calling the 21st Annual General Meeting. The report includes a correction to a typesetting error in the artwork of the Annual Report, which inadvertently included the name of a Non-Executive Director in the signatory sections of the Financial Statements. The corrected version of the Annual Report is available on the company's website.

Strides Pharma Science Ltd has completed a USFDA inspection at its Formulations Facility at Alathur, Chennai, with the USFDA issuing a Form 483 with three observations. The company will respond to these observations within the stipulated time.